Related Experiment Video
Updated: May 2, 2026
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
The oncological impact of complete transurethral resection before neoadjuvant chemotherapy in muscle-invasive bladder
C Fernandes1, I Baptista2, M Manso3
1Unidad de Salud Familiar São João, Oporto, Portugal.
Objectives:
To assess the impact of cTURBT on pathologic response. Secondary endpoints involved survival and oncologic outcomes.
Methods:
Tertiary centre data from patients with MIBC submitted to NAC and radical cystectomy between March 2010 and November 2022 was retrospectively analysed. Patients with complete resection (cTURBT) before NAC were compared to those with incomplete (iTURBT).
Results:
Thirty-seven patients were included in this study. NAC regime was identical between groups. cTURBT group demonstrated a higher rate of downstaging than the iTURBT group (50% vs 20%, p = 0.022). During the mean 49-month follow-up period, overall survival (86.4% vs. 40%, p=0.005), relapse-free survival (81.8% vs. 46.7% p=0.036), and cancer-specific survival (90.9% vs 60%, p=0.042) were higher in the cTURBT group. Furthermore, we observed significantly fewer relapses, higher survival rates, and lower oncological-related deaths in patients who exhibited downstaging.
Conclusion:
cTURBT demonstrated a favourable impact on patients with MIBC undergoing NAC, enhancing pathologic downstaging and improving survival outcomes. Our results can be confounded by cTURBT being a proxy for less aggressive disease.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
